Focus on painful clinical situations

OSTEOARTHRITIS: CURRENT SITUATION

Musculoskeletal disorders represent the fourth cause of disability following neuropsychiatric disorders, cancers and cardiovascular diseases in both developed and developing countries. These injuries include a variety of disorders that cause pain in bones, joints, muscles, and surrounding structures. Osteoarthritis (OA) is considered as the most common of the articular disorders and is frequently cited as [...]

FOCUS ON OXALIPLATIN-INDUCED PERIPHERAL NEUROPATHY: MECHANISMS AND PHARMACOLOGY

For this first blog, Laurent DIOP, Chief Scientific Officer at ANS Biotech, would like to focus on Neuropathic Pain and more specifically on Chemotherapy-induced peripheral neuropathy (CIPN). Since its creation in 2006, ANS Biotech is fully involved in this thematic and daily serves its Clients, all around the world, using relevant in vivo models for [...]

NEUROPATHIC PAIN: WHERE ARE WE TODAY ?

Neuropathic pain refers to the pain caused by damage or disease affecting the somatosensory nervous system and symptomized by a hypersensitivity. Today, Neuropathic Pain is relatively common, afflicting 7% to 8% of the population around the world. Various treatments exist in this field, but what is the real current situation ? The Neuropathic Pain market [...]
X